Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products.
about
Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouseMolecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and diseaseAcrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the ratFat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE).Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injuryLipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function.Hydralazine modifies Aβ fibril formation and prevents modification by lipids in vitro.Relationship of electrophilic stress to agingDetoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implicationsAcrolein-mediated injury in nervous system trauma and diseasesAdvanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycationAcrolein scavengers: reactivity, mechanism and impact on health.Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents.Diabetes-related adduct formation and retinopathy.Therapeutic potential of targeting lipid aldehydes and lipoxidation end-products in the treatment of ocular disease.Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease.Antiapoptotic effect of aminoguanidine on doxorubicin-induced apoptosis.NBHA reduces acrolein-induced changes in ARPE-19 cells: possible involvement of TGFβ.Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.Lipid-derived reactive aldehydes link oxidative stress to cell senescence.Critical role of acrolein in secondary injury following ex vivo spinal cord trauma.Modulation of therapy-induced senescence by reactive lipid aldehydesAminoguanidine changes hippocampal expression of apoptosis-related genes, improves passive avoidance learning and memory in streptozotocin-induced diabetic rats.Lipid Peroxide-Derived Short-Chain Carbonyls Mediate Hydrogen Peroxide-Induced and Salt-Induced Programmed Cell Death in Plants.Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord.CONTINUOUS INFUSION OF PHENELZINE, CYCLOSPORINE A OR THE COMBINATION: EVALUATION OF MITOCHONDRIAL BIOENERGETICS, OXIDATIVE DAMAGE AND CYTOSKELETAL DEGRADATION FOLLOWING SEVERE CONTROLLED CORTICAL IMPACT TRAUMATIC BRAIN INJURY IN RATS.Phenelzine Protects Brain Mitochondrial Function In Vitro and In Vivo following Traumatic Brain Injury by Scavenging the Reactive Carbonyls 4-Hydroxynonenal and Acrolein Leading to Cortical Histological Neuroprotection.Dimercaprol is an acrolein scavenger that mitigates acrolein-mediated PC-12 cells toxicity and reduces acrolein in rat following spinal cord injury.Effect of chronic intraperitoneal aminoguanidine on memory and expression of Bcl-2 family genes in diabetic rats.Carbonyl traps as potential protective agents against methimazole-induced liver injury.Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis.Carnosine Supplementation Improves Serum Resistin Concentrations in Overweight or Obese Otherwise Healthy Adults: A Pilot Randomized Trial
P2860
Q24630119-4F70772E-C2CD-436C-98D6-439553AF6C5FQ28081607-2BB519B9-484A-4B3B-AFF2-AA75266C850DQ30573749-6A14119F-14F3-40B4-A253-05815981BC26Q33627981-A84CA82D-AC41-4DA0-959C-35C8FEF8D82DQ34096164-34B4BE6A-DC30-4756-977B-F84E53E46DC8Q34142439-5E8FCAFB-EE49-4F44-8812-C328E3D74B52Q34549266-74BCB43B-F177-4D65-A237-A2C769E60590Q35165294-28D1AF8D-C1E7-4309-8BCD-54FB6C3C6800Q35565861-B7A5A6DE-A0E9-44CB-BD86-55DFE8E5E721Q36452743-F7419314-0704-4B97-B3B9-7918D2646DB9Q36887564-62F3ED95-8616-4F4A-8DC2-F944DB3F43E1Q37230025-586A4393-DFD6-467B-8893-B31808841D15Q37895630-3288E02A-167E-430F-8D13-B591BA17CD7DQ37909259-A9DC1FFC-A46C-4919-95E5-EEBB70F349ADQ38070160-E249EFB3-0268-4503-90E2-C1931663C686Q38077549-7D4D6A93-4891-46AE-AEF6-8095E87E2C7DQ38777574-D1FFB611-7CC3-41C9-A28A-DC2B16A9A607Q38993911-B51851C5-D897-4034-8523-1556B469862AQ39594704-B9271A56-5D83-4FFA-A61E-B1F6D9112C6CQ40060825-FA7254B7-CC70-42C1-86D5-8C98095C3706Q41432397-E70F7967-D606-48AA-A27B-D7C949771427Q41879134-00B13E33-38A3-4C37-94FB-57B3E7054620Q42407872-427FB391-606E-4AC4-8654-D6F3D23CE5D4Q45784169-21F41D65-A2C8-4419-958B-1213BC2CE34DQ46722032-7D89A0A3-BB9C-4C8D-B86F-1A352AE80B0DQ46905314-FFBB7172-41F4-422D-94CE-C8AAAB2B4352Q47656401-BA912015-B69D-4C70-A1AF-B2E1A39413ABQ48039001-26C1C3F4-FC3A-4A2B-A9AD-630FCFF19FE3Q48116579-F3AE4701-5542-4DE8-BF98-6F9B5A7695DBQ50510477-A835A292-1A75-4696-9D72-86EA0727366BQ53657514-E1FD6BFB-C5CF-41BC-81B3-93609CF8D3D8Q55497030-04EB71AB-356D-480B-876F-6BFA022CB2CBQ58758244-14FFDC03-A3B8-47B6-BA6A-B51C6D0D30F3
P2860
Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aldehyde-sequestering drugs: t ...... y lipid peroxidation products.
@ast
Aldehyde-sequestering drugs: t ...... y lipid peroxidation products.
@en
type
label
Aldehyde-sequestering drugs: t ...... y lipid peroxidation products.
@ast
Aldehyde-sequestering drugs: t ...... y lipid peroxidation products.
@en
prefLabel
Aldehyde-sequestering drugs: t ...... y lipid peroxidation products.
@ast
Aldehyde-sequestering drugs: t ...... y lipid peroxidation products.
@en
P2093
P1433
P1476
Aldehyde-sequestering drugs: t ...... by lipid peroxidation products
@en
P2093
Dennis R Petersen
Frank R Fontaine
Philip C Burcham
P304
P356
10.1016/S0300-483X(02)00287-1
P407
P478
P577
2002-12-01T00:00:00Z